Merck & Co. Inc. buy melinda
Start price
20.10.17
/
50%
€63.84
Target price
20.04.18
€66.00
Performance (%)
-6.62%
End price
20.04.18
€58.65
Summary
This prediction ended on 20.04.18 with a price of €58.65. With a performance of -6.62%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Merck & Co. Inc. | -1.961% | -1.961% | 2.881% | 39.841% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
According to melinda what are the pros and cons of Merck & Co. Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck and Company spezialisiert auf die Entwicklung unter Rezept verkauft, Herstellung und Vermarktung von therapeutischen Produkten und Impfstoffen. Der Umsatz ist Aktivität gliedern sich wie folgt: - Verkauf von pharmazeutischen Erzeugnissen (73,8%): für die Behandlung von Bluthochdruck
LYNPARZA hat das Potenzial , eine neue Behandlungsoption für Patienten mit metastasierendem HER2-negativen metastasierendem Brustkrebs bieten
(Laufzeit überschritten)
Stopped prediction by melinda for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€70.76
26.10.21
26.10.21
€65.00
26.10.22
26.10.22
38.64%
27.10.22
27.10.22
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€71.50
01.03.19
01.03.19
€77.00
04.11.21
04.11.21
-1.04%
26.10.21
26.10.21
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€57.58
20.10.17
20.10.17
€59.53
20.04.18
20.04.18
-6.62%
20.04.18
20.04.18
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€56.64
21.07.17
21.07.17
€59.53
14.09.17
14.09.17
5.90%
14.09.17
14.09.17
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€62.79
21.07.17
21.07.17
€66.00
14.09.17
14.09.17
5.90%
14.09.17
14.09.17
Could be worthwhile Investment >10% per year